TrialPloS one2020

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.

Eugènia Negredo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.